Microglia activation and anti-inflammatory regulation in Alzheimer's disease
about
The endocannabinoid system in normal and pathological brain ageingSUMOylation: Novel Neuroprotective Approach for Alzheimer's Disease?Microglial cell dysregulation in brain aging and neurodegenerationBrain innate immunity in the regulation of neuroinflammation: therapeutic strategies by modulating CD200-CD200R interaction involve the cannabinoid systemTSPO-specific ligand vinpocetine exerts a neuroprotective effect by suppressing microglial inflammationAlzheimer's disease and non-demented high pathology control nonagenarians: comparing and contrasting the biochemistry of cognitively successful agingGastrodin inhibits expression of inducible NO synthase, cyclooxygenase-2 and proinflammatory cytokines in cultured LPS-stimulated microglia via MAPK pathwaysBiochemical assessment of precuneus and posterior cingulate gyrus in the context of brain aging and Alzheimer's diseaseNitrone-based therapeutics for neurodegenerative diseases: their use alone or in combination with lanthionines.Microglia and memory: modulation by early-life infectionMathematical modeling for the pathogenesis of Alzheimer's disease.Microglia in Alzheimer's diseaseLeukocyte CCR2 expression is associated with mini-mental state examination score in older adults.Regulatory Effect of 25-hydroxyvitamin D3 on Nitric Oxide Production in Activated Microglia.Microglial P2X₇ receptor expression is accompanied by neuronal damage in the cerebral cortex of the APPswe/PS1dE9 mouse model of Alzheimer's disease.An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson's disease.Expression of suppressor of cytokine signaling genes in human elderly and Alzheimer's disease brains and human microgliaA cytokine mixture of GM-CSF and IL-3 that induces a neuroprotective phenotype of microglia leading to amelioration of (6-OHDA)-induced Parkinsonism of ratsA lifespan approach to neuroinflammatory and cognitive disorders: a critical role for glia.The impact of glial activation in the aging brainArizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program.Suppression of LPS-induced tau hyperphosphorylation by serum amyloid A.Pathogenesis of cognitive dysfunction in patients with obstructive sleep apnea: a hypothesis with emphasis on the nucleus tractus solitariusVitamin D interacts with Esr1 and Igf1 to regulate molecular pathways relevant to Alzheimer's diseaseDiagnostic and Predictive Levels of Calcium-binding Protein A8 and Tumor Necrosis Factor Receptor-associated Factor 6 in Sepsis-associated Encephalopathy: A Prospective Observational Study.Vitamin D, Cognition and Alzheimer's Disease: The Therapeutic Benefit is in the D-Tails.Phenotypic profile of alternative activation marker CD163 is different in Alzheimer's and Parkinson's disease.Possibility of a new anti-alzheimer's disease pharmaceutical composition combining memantine and vitamin D.The potential role of proinflammatory and antiinflammatory cytokines in Alzheimer disease pathogenesis.Review: microglia in protein aggregation disorders: friend or foe?Fibroblast growth factor-2 signaling in neurogenesis and neurodegeneration.Linking Alzheimer's disease and type 2 diabetes mellitus via aberrant insulin signaling and inflammation.Aggregation of the Inflammatory S100A8 Precedes Aβ Plaque Formation in Transgenic APP Mice: Positive Feedback for S100A8 and Aβ Productions.Neochlorogenic Acid Inhibits Lipopolysaccharide-Induced Activation and Pro-inflammatory Responses in BV2 Microglial Cells.Reversal of high fat diet-induced obesity improves glucose tolerance, inflammatory response, β-amyloid accumulation and cognitive decline in the APP/PSEN1 mouse model of Alzheimer's disease.Isoorientin attenuates lipopolysaccharide-induced pro-inflammatory responses through down-regulation of ROS-related MAPK/NF-κB signaling pathway in BV-2 microglia.Microglia: Housekeeper of the Central Nervous System.Microglia function in Alzheimer's disease.Immunomodulator CD200 Promotes Neurotrophic Activity by Interacting with and Activating the Fibroblast Growth Factor Receptor.Pharmacological use of a novel scaffold, anomeric N,N-diarylamino tetrahydropyran: molecular similarity search, chemocentric target profiling, and experimental evidence.
P2860
Q22242668-923C6467-E220-40E0-8A8D-AD9A834A5306Q26783370-94F9EC5B-BC97-4CFB-938A-5A99AC422EAAQ26800212-96B2857E-615C-4834-ACBB-796B20875637Q26865295-0D8DC3D8-9CEF-4660-AAB7-2C57AEF4134FQ28272695-0E8B5CF0-DE42-4943-941E-02AE6460BD7AQ28477836-27AEE1CD-B5C9-47FC-BA40-1C4079CB3451Q28478996-C97A7923-51A6-4F49-9D05-6FA743A4593DQ28542628-200A6651-0811-4321-9A60-E8C400B34F66Q30431810-ACF5982C-6B4F-4364-BDE1-02FB67F50D8DQ30468271-AE6CC3C7-87BB-4162-B64A-BF2CE82AA656Q33778539-67C9A2B8-4F89-4052-A6BC-5FAE973AD8AAQ34114020-F14D94D5-D703-4125-88C2-1F2FCD059E06Q34275897-3CB0AA72-4316-4C0E-A1B8-DE1D71249E1CQ34412516-D6322759-CE7A-4DA0-B0DE-40648FAE8B32Q34587134-ABFBF177-68FF-470F-97B8-7BEA196E15FAQ35057159-50F16669-C293-470B-9CA4-73F2BC5F5D95Q35272389-46ABD6C0-B4B3-455E-8ACF-7EF0A76B5E3CQ35554450-2EB29801-F8C5-4065-9B3D-9BC3B5E729CEQ35700368-BA185284-30BB-4C2E-A9AE-41BD534B042FQ35806715-E3987180-D564-4178-8AAA-17B4B063B10FQ36121377-CDCE01DA-C322-4D5C-BD44-AB0E6FB3596AQ36529499-4484EDC4-6573-4EF1-97BE-1F7434FF7830Q36635045-A0FF9CF5-2D66-4DC9-89AE-73CEECDAD089Q36639258-98DACB10-7082-43EA-BBA6-6DF671420FE3Q37126212-27218237-EE81-48F3-A57E-EE08144A17A1Q37144777-2C388A1B-2B84-4DDB-8D00-EAD4621A830BQ37612968-871A53F2-9198-4D2B-9C7B-6360CA43B044Q37974703-95307058-F655-4ED7-B371-BE6703641B90Q38042681-E05CE5F9-EA8E-4F93-BEA9-FEED8CF08AB7Q38075880-7912B0AF-BBAE-4AA4-9548-5E541D6A2D98Q38140658-BC66622D-32E1-47CB-AA6A-513DDD28DE53Q38145620-2FA3916B-79D2-4CC5-BB7F-E03DA2FC4708Q38774270-AC5BA191-B7D9-42E9-9C78-84398160FA15Q38855685-5DE13F1E-5D08-42A3-A596-58A8F5D5B19CQ39009113-35A12E58-D120-487B-AB4B-CDB77D0A7D77Q39082239-603701E4-4120-4ECF-9144-7DDFA66CF1E3Q39324141-42163C99-D296-4C59-A977-0AD6801D296EQ41014561-7F6EE85C-520A-4B98-931F-2D7ADA0C5D75Q41696569-39C0DCC9-17F7-4633-A213-A0C2FE65D5FDQ41998941-7DC62B0C-8B9A-4F4F-A7B0-57CE672DFC86
P2860
Microglia activation and anti-inflammatory regulation in Alzheimer's disease
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Microglia activation and anti-inflammatory regulation in Alzheimer's disease
@ast
Microglia activation and anti-inflammatory regulation in Alzheimer's disease
@en
type
label
Microglia activation and anti-inflammatory regulation in Alzheimer's disease
@ast
Microglia activation and anti-inflammatory regulation in Alzheimer's disease
@en
prefLabel
Microglia activation and anti-inflammatory regulation in Alzheimer's disease
@ast
Microglia activation and anti-inflammatory regulation in Alzheimer's disease
@en
P2093
P2860
P1476
Microglia activation and anti-inflammatory regulation in Alzheimer's disease
@en
P2093
Douglas G Walker
Lih-Fen Lue
Yu-Min Kuo
P2860
P2888
P304
P356
10.1007/S12035-010-8106-8
P577
2010-03-03T00:00:00Z
P5875
P6179
1011612624